Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum

Panacea Pharmaceuticals, Inc.

Q: What type of organization is Panacea Pharmaceuticals, Inc.?

Panacea Pharmaceuticals, Inc. is registered in NPPES as a Clinical Medical Laboratory (its primary provider taxonomy).

Clinical Medical Laboratory in Gaithersburg, MD · enumerated 2008 · authorized official Pamela Harris, Vp of Clinical and Medical Affairs.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1841455565

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)

Legal business name Panacea Pharmaceuticals, Inc.

Other name <Unavail>

Practice address 207 Perry Pkwy, Suite 2, Gaithersburg, MD, 20877

Phone (240) 243-8000

Fax (240) 465-0450

Enumeration date Jul 22, 2008

Last updated in NPPES Jul 22, 2008

Taxonomy & classification

291U00000X Clinical Medical Laboratory Laboratories · License 1352 (MD) Primary

Authorized official

Name Pamela Harris

Title Vp of Clinical and Medical Affairs

Phone (240) 243-8000

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What type of organization is Panacea Pharmaceuticals, Inc.?

Panacea Pharmaceuticals, Inc. is registered in NPPES as a Clinical Medical Laboratory (its primary provider taxonomy).

What is a Type 2 NPI?

A Type 2 NPI identifies an organization (group practice, hospital, pharmacy, lab), while Type 1 NPIs identify individual providers. Organizations bill under their Type 2 NPI.

Providers at this address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2008-07-22.